MTA3P1

Across TCGA pan-cancer cohorts, MTA3P1 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated MTA3P1 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher MTA3P1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated MTA3P1 expression acts as an unfavorable survival marker, although some lineages such as KIRP and ESCA show a favorable association.

KIRP, UCS, and ESCA are the cancer types where MTA3P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Tertile	III,IV	1.000	0.308	.017	49	view →
UCS	DFS	Tertile	II,III,IV	0.182	0.480	.012	42	view →
ESCA	OS	Tertile	III,IV	0.779	0.436	.002	24	view →
PRAD	DFS	Tertile	All	0.850	0.943	.001	18	view →
SKCM	OS	Tertile	IV	0.179	0.727	<.001	18	view →
LIHC	DFS	Tertile	All	0.316	0.549	.018	18	view →
OV	DFS	Quartile	IV	0.250	0.522	.004	16	view →
MESO	OS	Tertile	All	0.169	0.556	.043	9	view →
BLCA	DFS	Tertile	IV	0.227	0.486	.032	9	view →
KIRC	OS	Tertile	II,III,IV	0.407	0.575	.034	8	view →
GBM	OS	Tertile	All	0.588	0.378	.032	6	view →
STAD	OS	Tertile	III,IV	0.702	0.559	.025	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

MTA3P1–KIRP (OS)

Open the KIRP breakdown →